Preparation and therapeutic application of docetaxel-loaded poly(d,l-lactide) nanofibers in preventing breast cancer recurrence

References

• Ajani JA. (2006). The role of docetaxel in gastric cancer. Eur J Cancer Suppl 4:4–9
   Web of Science ®Google Scholar
• Arriagada R, Le M, Guinebreti RE, et al. (2003). Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 14:1617–22
   PubMed Web of Science ®Google Scholar
• Bergh J, Mariani G, Cardoso F, et al. (2012). Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer. Breast 21:507–13
   PubMed Web of Science ®Google Scholar
• Cai S, Xu H, Jiang Q, Yang Y. (2013). Novel 3D electrospun scaffolds with fibers oriented randomly and evenly in three dimensions to closely mimic the unique architectures of extracellular matrices in soft tissues: fabrication and mechanism study. Langmuir 29:2311–18
   PubMed Web of Science ®Google Scholar
• Ceruti M, Tagini V, Recalenda V, et al. (1999). Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions. Il Farmaco 54:733–9
   PubMedGoogle Scholar
• Choi JS, Leong KW, Yoo HS. (2008). In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 29:587–96
   PubMed Web of Science ®Google Scholar
• Chung CS, Harris JR. (2007). Post-mastectomy radiation therapy: translating local benefits into improved survival. Breast 16:78–83
   Web of Science ®Google Scholar
• Ernsting MJ, Foltz WD, Undzys E, et al. (2012). Tumor-targeted drug delivery using MR-contrasted docetaxel–carboxymethylcellulose nanoparticles. Biomaterials 33:3931–41
   PubMed Web of Science ®Google Scholar
• Farquhar CM, Marjoribanks J, Lethaby A, Basser R. (2007). High dose chemotherapy for poor prognosis breast cancer: systematic review and meta-analysis. Cancer Treat Rev 33:325–37
   PubMed Web of Science ®Google Scholar
• Fung LK, Saltzman WM. (1997). Polymeric implants for cancer chemotherapy. Adv Drug Deliv Rev 26:209–30
   PubMed Web of Science ®Google Scholar
• Ganta S, Singh A, Rawal Y, et al. (2014). Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.923068.
   PubMed Web of Science ®Google Scholar
• Gligorov J, Lotz JP. (2004). Preclinical pharmacology of the taxanes: implications of the differences. Oncologist 9:3–8
   PubMed Web of Science ®Google Scholar
• Gradishar WJ. (2001). Primary (neoadjuvant) chemotherapy with docetaxel in breast cancer. Clin Breast Cancer 2:S31–5
   PubMedGoogle Scholar
• Hennenfent K, Govindan R. (2006). Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol 17:735–49
   PubMed Web of Science ®Google Scholar
• Hwang H-Y, Kim I-S, Kwon IC, Kim Y-H. (2008). Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release 128:23–31
   PubMed Web of Science ®Google Scholar
• Kaye S, Piccart M, Aapro M, et al. (1997). Phase II trials of docetaxel (taxotere®) in advanced ovarian cancer – an updated overview. Eur J Cancer 33:2167–70
   PubMed Web of Science ®Google Scholar
• Kenawy E-R, Abdel-Hay FI, El-Newehy MH, Wnek GE. (2009). Processing of polymer nanofibers through electrospinning as drug delivery systems. Mater Chem Phys 113:296–302
   Web of Science ®Google Scholar
• Khadka DB, Haynie DT. (2012). Protein-and peptide-based electrospun nanofibers in medical biomaterials. Nanomed Nanotechnol Biol Med 8:1242–62
   PubMed Web of Science ®Google Scholar
• Lei N, Gong C, Qian Z, et al. (2012). Therapeutic application of injectable thermosensitive hydrogel in preventing local breast cancer recurrence and improving incision wound healing in a mouse model. Nanoscale 4:5686–93
   PubMed Web of Science ®Google Scholar
• Li M, Guo Y, Wei Y, et al. (2006). Electrospinning polyaniline-contained gelatin nanofibers for tissue engineering applications. Biomaterials 27:2705–15
   PubMed Web of Science ®Google Scholar
• Liu R, Khullar OV, Griset AP, et al. (2011). Paclitaxel-loaded expansile nanoparticles delay local recurrence in a heterotopic murine non-small cell lung cancer model. Ann Thorac Surg 91:1077–84
   PubMed Web of Science ®Google Scholar
• Liu R, Wolinsky JB, Catalano PJ, et al. (2012). Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy. Ann Surg Oncol 19:199–206
   PubMed Web of Science ®Google Scholar
• Liu R, Wolinsky JB, Walpole J, et al. (2010). Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films. Ann Surg Oncol 17:1203–13
   PubMed Web of Science ®Google Scholar
• Mazzaferro S, Bouchemal K, Skanji R, et al. (2012). Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly (isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan. J Control Release 162:568–74
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Raju A, Feng S-S. (2012). Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials 33:3494–501
   PubMed Web of Science ®Google Scholar
• Orlova Y, Magome N, Liu L, et al. (2011). Electrospun nanofibers as a tool for architecture control in engineered cardiac tissue. Biomaterials 32:5615–24
   PubMed Web of Science ®Google Scholar
• Petty WJ, Rathmann J, Dragnev KH, Rigas JR. (2002). The role of docetaxel in nonplatinum-based combination chemotherapy for non-small-cell lung cancer. Clin Lung Cancer 3:S12–16
   PubMedGoogle Scholar
• Qiu Y, Gao Y, Hu K, Li F. (2008). Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release 129:144–50
   PubMed Web of Science ®Google Scholar
• Ruel-Gari PY, Shive E, Bichara M, et al. (2004). A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm 57:53–63
   PubMed Web of Science ®Google Scholar
• Sampath D, Discafani CM, Loganzo F, et al. (2003). MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivo. Mol Cancer Ther 2:873–84
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang L, Gao H, et al. (2014). Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.990651
   Web of Science ®Google Scholar
• Vaishampayan U, Hussain M. (2008). Update in systemic therapy of prostate cancer: improvement in quality and duration of life. Expert Rev Anticancer Ther 8:269–81
   Google Scholar
• Voogd A, van Oost F, Rutgers E, et al. (2005). Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 41:2637–44
   PubMed Web of Science ®Google Scholar
• Wang L, Liu Z, Liu D, et al. (2011). Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm 413:194–201
   PubMed Web of Science ®Google Scholar
• Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, et al. (2006). Insights into the mechanism of microtubule stabilization by Taxol. Proc Natl Acad Sci 103:10166–73
   PubMed Web of Science ®Google Scholar
• Yanasarn N, Sloat BR, Cui Z. (2009). Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel. Int J Pharm 379:174–80
   PubMed Web of Science ®Google Scholar
• Yoo HS, Kim TG, Park TG. (2009). Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Adv Drug Deliv Rev 61:1033–42
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Liu T, et al. (2014). Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.916768
   Web of Science ®Google Scholar